BridgeBio Pharma (NASDAQ:BBIO) reported its Q4 earnings results on Thursday, February 22, 2024 at 07:30 AM.
Here’s what investors need to know about the announcement.
Earnings
BridgeBio Pharma missed estimated earnings by 5.49%, reporting an EPS of $-0.96 versus an estimate of $-0.91.
Revenue …
Leave a Reply